3D Microfluidic Cell Culture Market Size Estimated at USD 393.95 Million, with 15.8% CAGR From 2024-2032 - PMR

Progression in tissue engineering is a major factor driving the 3D microfluidic cell culture market growth.

NEW YORK CITY, NY, UNITED STATES, October 1, 2024 /EINPresswire.com/ -- The 3D microfluidic cell culture market report by Polaris Market Research offers a comprehensive analysis of the market, covering all the major aspects to help stakeholders make informed decisions.

𝐓𝐡𝐞 3𝐃 𝐦𝐢𝐜𝐫𝐨𝐟𝐥𝐮𝐢𝐝𝐢𝐜 𝐜𝐞𝐥𝐥 𝐜𝐮𝐥𝐭𝐮𝐫𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐨𝐧 𝐚 𝐠𝐫𝐨𝐰𝐭𝐡 𝐭𝐫𝐚𝐣𝐞𝐜𝐭𝐨𝐫𝐲. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 393.95 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2032, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 15.8% 𝐟𝐫𝐨𝐦 2024 𝐭𝐨 2032. 𝐈𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 105.21 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023.

𝐖𝐡𝐚𝐭 𝐢𝐬 3𝐃 𝐌𝐢𝐜𝐫𝐨𝐟𝐥𝐮𝐢𝐝𝐢𝐜 𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞?
3D cell culture is a culture ambiance that permits cells to evolve and communicate with bordering extracellular structures in three dimensions. This conflicts with conventional 2D cell cultures in which cells are grown in a flat monolayer or a plate. 3D cell cultures can be extended with or without a reinforcing scaffold. In the scaffold 3D cultures, 3D cells might be cultured within a reinforcing scaffold to permit growth universally. Polymeric substances entail a framework of interconnected polymer chains that can soak up and preserve water. Hydrogels can be emanated from animals or plants or synthesized from chemicals.

3D cell cultures have become growingly favored as they are more physiologically pertinent and better constitute in vivo tissue. No cell types within the body develop as monolayers autonomous of other cells or tissue. Rather, most cells organically prevail in intricate 3D frameworks involving varied cell types within an extracellular matrix. The innumerable cell-to-cell and cell-matrix interplay all have a sizeable impact on the behavior. The surge in detrimental illnesses and the push for customized medicines are impacting the 3D microfluidic cell culture market growth favorably.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/3d-microfluidic-cell-culture-market/request-for-sample

𝐖𝐡𝐨 𝐌𝐚𝐤𝐞𝐬 3𝐃 𝐌𝐢𝐜𝐫𝐨𝐟𝐥𝐮𝐢𝐝𝐢𝐜 𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞?

• Emulate Inc.
• TissUse GmbH
• MIMETAS BV
• InSphero AG
• CN Bio Innovations Ltd.
• Kirkstall Ltd.
• Hurel Corporation
• AIM Biotech
• Elveflow
• Blacktrace Holdings Ltd.
• Tara Biosystems Inc.
• Ascendance Biotechnology Inc.
• Synthecon Incorporated
• Fluidigm Corporation
• Organovo Holdings Inc.

are some of the leading players in the 3D microfluidic cell culture market.

The firms are spearheading the market through ongoing invention, sizeable research and development ventures, and deliberate alliances to progress the potential of 3D microfluidic technologies. Some of the latest developments in the market are:
• In May 2023, Emulate Inc. declared an alliance with the US Food and Drug Administration (FDA) to assess their liver chip platform for toxicology testing. It is a notable stride towards the administrative approval of organ-on-a-chip technologies in drug security evaluation.

• In March 2023, MIMETAS declared the instigation of the contemporary category of their organoplate 3 lane, which permits even more intricate tissue culture models, improving the platform's usage in organ-on-a-chip and illness research entreaties.

𝐖𝐡𝐚𝐭’𝐬 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐰𝐚𝐫𝐝?
Technological Progressions: The amalgamation of artificial intelligence and machine learning into 3D microfluidic cell culture systems is converting the topography of biomedical research and drug advancement. These technologies sanction the automation and maximization of exploratory procedures permitting for real-time investigation and translation of intricate biological data.

Productive Drug Detection Procedures: High throughput screening platforms are becoming increasingly frequent in the market, pushed by the requirement for more productive drug detection procedures. Conventional drug screening practices are often tedious and need extensive proportions of reagents and specimens. This, in turn, is having a favorable impact on 3D microfluidic cell culture market sales.

Progression in Tissue Engineering: The market is witnessing sizeable growth due to progressions in tissue engineering and regenerative medicines. These procedures offer a more precise portrayal of human tissues and organs, sanctioning researchers to consider intricate biological procedures in a regulated environment.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/3d-microfluidic-cell-culture-market/request-for-discount-pricing

𝐖𝐡𝐢𝐜𝐡 𝐑𝐞𝐠𝐢𝐨𝐧 𝐋𝐞𝐚𝐝𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡?
North America: North America accounted for the largest 3D microfluidic cell culture market share. The region’s robust growth is primarily due to its robust existence of pharmaceutical and biotechnology firms, sizeable research and advancement ventures, and sizeable funding in progressive medical technologies.

Europe: Europe is anticipated to witness significant growth from 2024 to 2032. This can be attributed to speedy growth due to growing funding in healthcare framework and research capabilities.

𝐇𝐨𝐰 𝐈𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐃𝐨𝐧𝐞?
By Component Outlook:
• 3D Microfluidic Devices
• Media
• Reagents
• Consumables

By Application Outlook:
• Drug Discovery & Development
• Tissue Engineering
• Regenerative Medicine
• Cancer Research
• Stem Cell Research
• Organ-on-a-Chip
• Toxicology Testing
• Disease Modeling
• Others

By End-User Outlook:
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Diagnostic Centers
• Contract Research Organizations (CROs)
• Others

By Region Outlook:
• North America (US, Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Australia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐞𝐟𝐨𝐫𝐞 𝐩𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/3d-microfluidic-cell-culture-market/inquire-before-buying

𝐅𝐀𝐐𝐬:
How much is the global 3D microfluidic cell culture market?
The market size was valued at USD 105.21 million in 2023 and is projected to grow to USD 393.95 million by 2032.

What is the 3D microfluidic cell culture market growth rate?
The global market is projected to register a CAGR of 15.8% during the forecast period, 2023-2032.

Which region held the largest market share?
North America had the largest share of the global market.

Which application dominates the market?
The drug discovery and development segment dominated the market in 2023.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭:
https://www.polarismarketresearch.com/industry-analysis/biotechnology-market

𝐄-𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭:
https://www.polarismarketresearch.com/industry-analysis/e-pharma-market

𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭:
https://www.polarismarketresearch.com/industry-analysis/cell-culture-market

𝐕𝐢𝐫𝐮𝐬 𝐅𝐢𝐥𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭:
https://www.polarismarketresearch.com/industry-analysis/virus-filtration-market

𝐕𝐢𝐬𝐜𝐨𝐬𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭:
https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.

Likhil G
Polaris Market Research and Consulting
+ +1 929-297-9727
sales@polarismarketresearch.com
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.